Alira Health Partners with Policy Matters to Foster Market Access in the UK

The partnership strengthens the company’s global consulting services throughout its presence in Northern Europe.

News
Published on:
November 15, 2022

Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist consultancy Policy Matters. Policy Matters is an independent consultancy offering end-to-end market access solutions. The Alira Health and Policy Matters partnership allows Alira Health to reach clients based in the UK through dedicated regional projects while fostering the company’s global market access solutions through the expertise of one of the most experienced local access companies in the UK.

It is an honour for us to join forces with Policy Matters, a cooperation that further expands our global reach. Policy Matters has an over twenty-year reputation for securing funding for some of the most innovative treatments now available on the NHS, as well as providing decades long support to industry collectives and organisations. This means that our clients will benefit from the expertise of the very senior and highly skilled team of Policy Matters UK specialists, while having seamless access to the array of Alira Health services we offer including strategic consulting and tailored solutions.
Nerea Blanqué-Catalina Senior Vice President Global Market Access at Alira Health
In the post-Brexit world our clients need a team that knows the UK intimately - regulatory, access routes and pricing, that is able to ensure reimbursement is successfully secured, while being cognisant of the impact of the UK on European and other markets and vice versa. The UK market is increasingly complex and challenging. Over the years we have worked alongside several HEOR and pricing consultancies but have finally found one that perfectly complements our offering.
Beverley Evans Partner at Policy Matters
About Alira Health

Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle.

Learn more: www.alirahealth.com

About Policy Matters

Policy Matters is an independent UK based market access and healthcare policy consultancy offering dynamic and effective bespoke, integrated access strategies, based on their exceptional understanding of the constantly evolving UK healthcare and access environment. They focus on companies that develop and supply medicines, technologies, devices, and services to UK National Health Service (NHS) organizations.

Learn more: www.policy-matters.com

Related news

News November 15, 2022
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Digital Health Healthcare Consulting Market Access
News November 10, 2022
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE
Events October 7, 2022
Debate Sobre los IPT en Oncología
We are pleased to announce our next event, “Debate Sobre los IPT en Oncología,” focusing on price and reimbursement (P&R) of vital oncology and oncohematology therapies.
Market Access Product Development Regulatory
Publications October 5, 2022
Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain
Discover how companies’ target prices are impacted by the different variables leveraged during the P&R process for oncology and oncohematology’s first indication.
Market Access Oncology Spain
News October 4, 2022
Alira Health enhances its market access services through a strategic partnership with Centivis
Alira Health, a global healthcare advisory and technology company, announced a strategic partnership with Centivis AG, a boutique market access consulting agency, specializing in digital(...)
Digital Health Market Access MedTech Pharma Regulatory
Events September 30, 2022
XV Congresso Nazionale Sihta
We are pleased to share that we will be joining as speakers and sponsors XV Congresso Nazionale Sihta, a key event for Italian Healthcare industry.
Digital Health Real-World Evidence
News September 27, 2022
AseBio and Alira Health Partner to Foster Market Access for Biotech Startups
Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.
Biotech Market Access Startups
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.